|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C12Q 1/68 |
| (11) | Number of the document | 2894231 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15151581.4 |
| Date of filing the European patent application | 2010-08-03 | |
| (97) | Date of publication of the European application | 2015-07-15 |
| (45) | Date of publication and mention of the grant of the patent | 2017-01-04 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 09167184 | 2009-08-04 | EP |
| (72) |
Foernzler, Dorothee, CH
Delmar, Paul, CH
Scherer, Stefan, CH
Lambrechts, Diether, BE
Carmeliet, Peter, BE
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
VIB vzw, Rijvisschestraat 120, 9052 Gent, BE Life Sciences Research Partners VZW, Campus Gasthuisberg Herestraat 49, bus 913, 3000 Leuven, BE |
| (54) | Responsiveness to angiogenesis inhibitors |
| Responsiveness to angiogenesis inhibitors |